BOVALTO PASTOBOV
BOVALTO PASTOBOV
Not authorised
- Mannheimia haemolytica, serotype A1, strain NL 1009, leucotoxoid
Product identification
Medicine name:
PASTOBOV
BOVALTO PASTOBOV
Active substance:
- Mannheimia haemolytica, serotype A1, strain NL 1009, leucotoxoid
Target species:
-
Cattle
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Mannheimia haemolytica, serotype A1, strain NL 1009, leucotoxoid68.00/enzyme-linked immunosorbent assay unit1.00Dose
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Cattle
-
All relevant tissues0day
-
-
Subcutaneous use
- Cattle
-
All relevant tissues0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI02AB04
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Ireland
Package description:
- Box of 10 glass bottles of 1 dose
- Box of 50 glass bottles of 1 dose
- Box of 100 glass bottles of 1 dose
- Box of 5 dose-glass bottle.
- Box of 10 glass bottles of 5 doses
- Box of 10 dose-glass bottle
- Box of 10 glass bottles of 10 doses
- Box of 1 dose-glass bottle
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- HPRA
Authorisation number:
- VPA10454/028/001
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0101/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
